Feng‐Wei Chen
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Cytokine Signaling Pathways and Interactions
Papers in
- Oncology 4
- Cytokine Signaling Pathways and Interactions 2
- Cancer Immunotherapy and Biomarkers 1
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Co-authors
- Ming‐Shi Chang (2 shared papers)Jiann‐Jou Yang (1 shared paper)W. F. Liang (1 shared paper)Ju‐Ming Wang (6 shared papers)Yu‐Wei Hsiao (3 shared papers)Ming‐Derg Lai (3 shared papers)Chih‐Peng Chang (2 shared papers)Chih-Yang Wang (3 shared papers)
- Journals
- Frontiers in Cell and Developmental Biology (2 papers)Journal of Biomedical Science (1 paper)Aging (1 paper)The Journal of Immunology (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- TaiwanVietnamUnited Arab Emirates
In The Last Decade
Feng‐Wei Chen
11 papers receiving 454 citations
Peers
Comparison fields: 5 of 73
- Infectious Diseases 112
- Oncology 86
- Immunology 61
- Hepatology 19
- Cancer Research 27
Countries citing papers authored by Feng‐Wei Chen
This map shows the geographic impact of Feng‐Wei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng‐Wei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng‐Wei Chen more than expected).
Fields of papers citing papers by Feng‐Wei Chen
This network shows the impact of papers produced by Feng‐Wei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng‐Wei Chen. The network helps show where Feng‐Wei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng‐Wei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 281 | |
| 2 | 2023 | 41 | |
| 3 | 2021 | 35 | |
| 4 | 2021 | 26 | |
| 5 | 2024 | 22 | |
| 6 | 2022 | 20 | |
| 7 | 2019 | 18 | |
| 8 | A novel combination therapy of arginine deiminase and an arginase inhibitor targeting arginine metabolism in the tumor and immune microenvironment. | 2023 | 12 |
| 9 | 2006 | 8 | |
| 10 | 2024 | 6 | |
| 11 | 2021 | 4 |
About Feng‐Wei Chen
Feng‐Wei Chen is a scholar working on Oncology, Hepatology, Immunology, Biochemistry and Biotechnology, having authored 11 papers that have together received 473 indexed citations. Recurring topics across this work include Immune cells in cancer (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Autophagy in Disease and Therapy (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Acute Kidney Injury Research (1 paper) and Genomics and Chromatin Dynamics (1 paper). The work is most often cited by research in Infectious Diseases (112 citations), Oncology (86 citations), Immunology (61 citations), Hepatology (19 citations) and Cancer Research (27 citations). Feng‐Wei Chen has collaborated with scholars based in Taiwan, Vietnam and United Arab Emirates. Frequent co-authors include Ming‐Shi Chang, Jiann‐Jou Yang, W. F. Liang, Ju‐Ming Wang, Yu‐Wei Hsiao, Ming‐Derg Lai, Chih‐Peng Chang, Chih-Yang Wang, Chien-Feng L Li and Liang‐Yi Hung. Their work appears in journals such as Frontiers in Cell and Developmental Biology, Journal of Biomedical Science, Aging, The Journal of Immunology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.